Newsletter | February 4, 2025

02.04.25 -- How Recce Is Delivering 5,000 Doses Per Week For Its Clinical Trials

FEATURED EDITORIAL

How Recce Is Delivering 5,000 Doses Per Week For Its Clinical Trials

Automation and the underlying chemistry of its R327 candidate have helped the antibiotic developer reach notably high production volumes.

INDUSTRY INSIGHTS

Treating Deficiencies In Employee Training And Mentorship

Investing in employee training and development is not just beneficial for the employees. It also contributes significantly to the organization’s success and competitive advantage.

Overcoming The Challenges Of Fragmented Supply Chains

As trials grow more complex, managing supplies is increasingly challenging. In a recent webinar, experts discussed forecasting, GxP inventory management, and integrated solutions to overcome these hurdles.

Artificial Intelligence Regulation

To make the best use of artificial intelligence (AI), drug sponsors need to understand where health authorities are drawing the lines.

The Difference Between A Traditional IRT And Rave RTSM

Examine the differences between Traditional IRT and Rave RTSM, highlighting key attributes like workflow integration, user management, and overall impact on clinical trial operations.

SOLUTIONS

Understanding Options In Direct-To-Patient Clinical Supply